COVID-19 susceptibility mechanism discovered using a newly created tool

Researchers have discovered a mechanism for COVID-19 susceptibility using a newly created tool. The tool, GASPACHO, captures dynamic changes in gene expression along the innate immune response, allowing researchers to identify genes and molecular pathways associated with disease risk that have previously been too complex to detect or interpret. Using GASPACHO (GAuSsian Processes for Association mapping leveraging Cell HeterOgeneity), researchers […]

Continue reading »

Long COVID: Diabetes drug metformin could reduce risk

Researchers evaluated whether a common diabetes medication, metformin, can prevent long COVID. They found that metformin can reduce long COVID diagnoses by 40%. Further studies are needed to know if these findings apply to the general population. Long COVID is characterized by ongoing health problems that occur after a COVID-19 diagnosis, and which cannot be explained by other factors. Symptoms […]

Continue reading »

Transgenic mouse model reveals surprising new connections between peripheral nerves and the heart

Oxidative stress – characterized by elevated levels of unstable molecules called reactive oxygen species– is associated with neurodegeneration and cardiovascular disease. However, until recently it has not been possible to demonstrate a causal relationship between oxidative stress and disease states. A new study used "chemogenetics" to activate a recombinant yeast protein expressed in mouse tissues to manipulate levels of oxidative […]

Continue reading »

New tool predicts if immunotherapy will mistakenly attack healthy cells

Researchers at the University of Houston are working to make T-cell immunotherapy safer, developing a tool called CrossDome, which uses a combination of genetic and biochemical information to predict if T-cell immunotherapies might mistakenly attack healthy cells. T-cell based immunotherapies hold tremendous potential in the fight against cancer and infectious diseases, thanks to their capacity to specifically target diseased cells, […]

Continue reading »

Novel approach could redefine allergy treatment

For years, research and therapies for allergic asthma have been focused largely on targeting the inflammatory cytokines in the body that react to allergens and cause overproduction of mucus, wheezing and difficulty breathing. Commonly prescribed drugs like omalizumab, dupilumab, mepolizumab and reslizumab lower or block the various cytokines and antibodies responsible for the asthmatic response, but they work after a […]

Continue reading »

BU assistant professor of medicine receives the 2023 Excellence in LGBTQ Health Award

Carl G. Streed, MD, MPH, FACP, FAHA, an assistant professor of medicine at Boston University Chobanian and Avedisian School of Medicine and the research lead for the GenderCare Center at Boston Medical Center (BMC), has received the 2023 Excellence in LGBTQ Health Award (Physician) from the American Medical Association (AMA) Foundation Board of Directors. This annual award honors physicians who […]

Continue reading »
1 118 119 120 121 122 1,322